Entry status  (1)

REL

(164)

Experimental methods  (1)

X-ray diffraction

(164)

Authors  (910)

Silvennoinen O

(33)

Schlessinger J

(25)

Haikarainen T

(23)

Puleo DE

(22)

Jorgensen WL

(21)

Newton AS

(20)

Schonbrunn E

(19)

Hubbard SR

(18)

Virtanen AT

(17)

Ayaz M

(15)

Chan A

(15)

Davis RR

(15)

Gunawan S

(15)

Lawrence HR

(15)

Lawrence NJ

(15)

Li B

(15)

Nareddy P

(15)

Reuther GW

(15)

Schönbrunn E

(15)

Yun SY

(15)

Eigenbrot C

(13)

Liu J

(13)

Liukkonen S

(13)

Nekhotiaeva N

(13)

Palmroth M

(13)

Sampathkumar P

(13)

Chang C

(12)

Ultsch M

(12)

Cutrona KJ

(11)

Ghilardi N

(11)

Gibbons P

(11)

Krimmer SG

(11)

Liosi ME

(10)

Radimerski T

(10)

Vangrevelinghe E

(10)

Barrett K

(9)

Blair WS

(9)

Hurley CA

(9)

Johnson A

(9)

Kenny JR

(9)

Shia S

(9)

Ungureanu D

(9)

Bennani YL

(8)

Chene P

(8)

Chène P

(8)

Eck MJ

(8)

Hogan JK

(8)

Ledeboer MW

(8)

Liimatta M

(8)

McNally R

(8)

Pierce AC

(8)

Salituro FG

(8)

Shlyakter D

(8)

Zuccola HJ

(8)

Bir Kohli P

(7)

Dekker C

(7)

Fan B

(7)

Hilpert M

(7)

Hoock T

(7)

Jones M

(7)

Li K

(7)

Li Q

(7)

Machauer R

(7)

Mahajan S

(7)

Miao Y

(7)

Skoda RC

(7)

Virtanen A

(7)

Wang T

(7)

Xiao Y

(7)

Zmajkovic J

(7)

van Abbema A

(7)

Babon JJ

(6)

Brown DG

(6)

Chrencik J

(6)

Chrencik JE

(6)

Coe JW

(6)

Dehnhardt CM

(6)

Deshmukh G

(6)

England KS

(6)

Hammaren HM

(6)

Hammarén HM

(6)

Johnson T

(6)

Jones P

(6)

Jones RM

(6)

Kershaw NJ

(6)

Kilty I

(6)

Kortum SW

(6)

Kucera K

(6)

Kulagowski JJ

(6)

Lippy J

(6)

Lombardo LJ

(6)

Lorenzi MV

(6)

Mendonca R

(6)

Messersmith D

(6)

Morgan P

(6)

Mukaiyama T

(6)

Murphy JR

(6)

Murray J

(6)

Purandare AV

(6)

Sabnis YA

(6)

 

More...

Homo / hetero assembly  (2)

homo

(155)

hetero

(9)

Assembly composition  (2)

protein structure

(155)

protein/protein complex

(9)

Assembly polymer count  (3)

monomer

(151)

dimer

(12)

trimer

(1)

Resolution distribution

1.0 - 1.5

(17)

1.5 - 2

(67)

2.0 - 2.5

(61)

2.5 - 3

(15)

3.0 - 3.5

(3)

3.5 - 4

(1)

Release year distribution

2005 - 2010

(14)

2010 - 2015

(43)

2015 - 2020

(54)

2020 - 2025

(74)

Journal  (24)

J Med Chem

(66)

Bioorg Med Chem Lett

(16)

ACS Med Chem Lett

(15)

Pharmaceuticals (Basel)

(13)

To be published

(9)

ACS Chem Biol

(7)

Bioorg Med Chem

(5)

Blood

(5)

Commun Biol

(4)

Nat Struct Mol Biol

(4)

Sci Adv

(3)

Elife

(2)

Eur J Med Chem

(2)

J Mol Biol

(2)

Tetrahedron Lett.

(2)

Biochem J

(1)

Blood Cancer J

(1)

Cancer Discov

(1)

Cell Chem Biol

(1)

J Chem Theory Comput

(1)

J Exp Med

(1)

Mol Cancer Ther

(1)

PLoS One

(1)

Sci Transl Med

(1)

Organism superkingdom  (1)

Eukaryota

(164)

Organism name  (2)

Homo sapiens

(162)

Mus musculus

(2)

Molecule name  (3)

JAK-2

(164)

Janus kinase 2

(164)

Tyrosine-protein kinase JAK2

(164)

Molecule type  (1)

Protein

(164)

Gene names  (2)

JAK2

(162)

Jak2

(2)

Interacting Molecules  (7)

Tyrosine-protein phosphatase non-receptor type 1

(4)

Erythropoietin receptor

(1)

Interleukin-6 receptor subunit beta

(1)

Leptin receptor

(1)

SH2B adapter protein 1

(1)

SH2B adapter protein 3

(1)

Suppressor of cytokine signaling 3

(1)

Interacting ligands  (142)

GOL : GLYCEROL

(41)

ACT : ACETATE ION

(10)

EDO : 1,2-ETHANEDIOL

(8)

DMS : DIMETHYL SULFOXIDE

(7)

SKE : 4-({5-amino-1-[(2,6-difluorophenyl)carbonyl]-1H-1,2,4-triazol-3-yl}amino)benzenesulfonamide

(5)

ATP : ADENOSINE-5'-TRIPHOSPHATE

(4)

MG : MAGNESIUM ION

(4)

35R : 1-cyclopropyl-3-{3-[5-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl}urea

(3)

AQG : 4-{[6-(cyclohexylmethoxy)-7H-purin-2-yl]amino}-N,N-diethylbenzamide

(3)

MLI : MALONATE ION

(3)

RXT : (3R)-3-cyclopentyl-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]propanenitrile

(3)

SO4 : SULFATE ION

(3)

046 : 5-{[6-(acetylamino)pyrimidin-4-yl]oxy}-N-{4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl}-2,3-dihydro-1H-indole-1-carboxamide

(2)

1M3 : N-tert-butyl-3-[(5-methyl-2-{[4-(4-methylpiperazin-1-yl)phenyl]amino}pyrimidin-4-yl)amino]benzenesulfonamide

(2)

2HB : N-(5-{4-[(1,1-dioxidothiomorpholin-4-yl)methyl]phenyl}[1,2,4]triazolo[1,5-a]pyridin-2-yl)cyclopropanecarboxamide

(2)

3JW : Baricitinib

(2)

AD5 : N~6~-cyclohexyl-N~2~-(4-morpholin-4-ylphenyl)-9H-purine-2,6-diamine

(2)

DQX : 8-[3,5-difluoro-4-(morpholin-4-ylmethyl)phenyl]-2-(1-piperidin-4-yl-1H-pyrazol-4-yl)quinoxaline

(2)

IZA : 2-TERT-BUTYL-9-FLUORO-3,6-DIHYDRO-7H-BENZ[H]-IMIDAZ[4,5-F]ISOQUINOLINE-7-ONE

(2)

PO4 : PHOSPHATE ION

(2)

Q7F : 6-[[methyl-[(3-methylthiophen-2-yl)methyl]amino]methyl]-~{N}4-phenyl-1,3,5-triazine-2,4-diamine

(2)

Q8U : 1-(3,4-diazatricyclo[9.4.0.0^{2,7}]pentadeca-1(11),2(7),3,5,12,14-hexaen-5-yl)-~{N}3-[(7~{S})-7-pyrrolidin-1-yl-6,7,8,9-tetrahydro-5~{H}-benzo[7]annulen-3-yl]-1,2,4-triazole-3,5-diamine

(2)

R6V : (3R)-3-cyclopentyl-3-[4-(2-{[4-(piperidin-4-yl)phenyl]amino}-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]propanenitrile

(2)

T7I : 3,5-diphenyl-2-(trifluoromethyl)-1~{H}-pyrazolo[1,5-a]pyrimidin-7-one

(2)

0NH : 1-[4-methyl-1-(methylsulfonyl)piperidin-4-yl]-1,6-dihydroimidazo[4,5-d]pyrrolo[2,3-b]pyridine

(1)

0NU : 3-[(3R)-3-(imidazo[4,5-d]pyrrolo[2,3-b]pyridin-1(6H)-yl)piperidin-1-yl]-3-oxopropanenitrile

(1)

0NV : 1-(1-benzylpiperidin-4-yl)-1,6-dihydroimidazo[4,5-d]pyrrolo[2,3-b]pyridine

(1)

0TP : 4-amino-N-methyl-2-[4-(morpholin-4-yl)phenyl]thieno[3,2-c]pyridine-7-carboxamide

(1)

0X2 : 2,6-dichloro-N-(2-oxo-2,5-dihydropyridin-4-yl)benzamide

(1)

0X5 : 2,6-dichloro-N-{2-[(cyclopropylcarbonyl)amino]pyridin-4-yl}benzamide

(1)

15V : N-[1-(3-chlorophenyl)-3-methyl-1H-pyrazol-5-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide

(1)

17P : 1-(cyclohexylamino)-7-(1-methyl-1H-pyrazol-4-yl)-5H-pyrido[4,3-b]indole-4-carboxamide

(1)

1J5 : trans-4-{2-[(1R)-1-hydroxyethyl]imidazo[4,5-d]pyrrolo[2,3-b]pyridin-1(6H)-yl}cyclohexanecarbonitrile

(1)

1K3 : 5-(4-methoxyphenyl)-N-[4-(4-methylpiperazin-1-yl)phenyl][1,2,4]triazolo[1,5-a]pyridin-2-amine

(1)

1P5 : (3S)-1-[6-(2-aminopyrazolo[1,5-a]pyrimidin-3-yl)pyrimidin-4-yl]-N,N-diethylpiperidine-3-carboxamide

(1)

1P6 : 3-(6-{[(1S)-1-(4-fluorophenyl)ethyl]amino}pyrimidin-4-yl)pyrazolo[1,5-a]pyrimidin-2-amine

(1)

1RS : 1-(piperidin-4-yl)-1,6-dihydroimidazo[4,5-d]pyrrolo[2,3-b]pyridine

(1)

2TA : N-tert-butyl-3-{[5-methyl-2-({4-[2-(pyrrolidin-1-yl)ethoxy]phenyl}amino)pyrimidin-4-yl]amino}benzenesulfonamide

(1)

2V9 : Lestaurtinib

(1)

36H : 2-((1-(2-fluoro-4-((4-(1-isopropyl-1H-pyrazol-4-yl)-5-methylpyrimidin-2-yl)amino)phenyl)piperidin-4-yl)(methyl)amino)ethan-1-ol

(1)

3KC : 3-chloro-4-(4H-3,4,7-triazadibenzo[cd,f]azulen-6-yl)phenol

(1)

3O4 : N-[4-[2-[(4-morpholin-4-ylphenyl)amino]pyrimidin-4-yl]phenyl]ethanamide

(1)

3YT : 2-{[(1R,2S)-2-aminocyclohexyl]amino}-4-{[3-(2H-1,2,3-triazol-2-yl)phenyl]amino}pyrimidine-5-carboxamide

(1)

467 : N~2~-[2-(5-chloro-1H-pyrrolo[2,3-b]pyridin-3-yl)-5-fluoropyrimidin-4-yl]-2-methyl-N-(2,2,2-trifluoroethyl)-D-alaninamide

(1)

4HW : N~3~-phenyl-1-[6-(phenylamino)pyrimidin-4-yl]-1H-1,2,4-triazole-3,5-diamine

(1)

4HZ : N~2~-[2-(5-chloro-1H-pyrrolo[2,3-b]pyridin-3-yl)-5-fluoropyrimidin-4-yl]-N-(2,2,2-trifluoroethyl)-L-alaninamide

(1)

4LY : [3-(4-{2-[3,5-difluoro-4-(1-methyl-1,2,3,6-tetrahydropyridin-4-yl)anilino]-7H-pyrrolo[2,3-d]pyrimidin-4-yl}-1H-pyrazol-1-yl)-1-(ethanesulfonyl)azetidin-3-yl]acetonitrile

(1)

4OK : 3-(3,4-dichlorophenyl)-6-(morpholin-4-ylcarbonyl)-9H-carbazole-1-carboxamide

(1)

4SP : O6-CYCLOHEXYLMETHOXY-2-(4'-SULPHAMOYLANILINO) PURINE

(1)

50O : N,N-dicyclopropyl-6-[(2S)-2,3-dihydroxypropyl]-1-methyl-4-(methylamino)-1,6-dihydroimidazo[4,5-d]pyrrolo[2,3-b]pyridine-7-carboxamide

(1)

50V : N,N-dicyclopropyl-4-[(1,5-dimethyl-1H-pyrazol-3-yl)amino]-6-ethyl-1-methyl-1,6-dihydroimidazo[4,5-d]pyrrolo[2,3-b]pyridine-7-carboxamide

(1)

50W : N,N-dicyclopropyl-4-[(4,5-dimethyl-1,3-thiazol-2-yl)amino]-6-ethyl-1-methyl-1,6-dihydroimidazo[4,5-d]pyrrolo[2,3-b]pyridine-7-carboxamide

(1)

50Y : N,N-dicyclopropyl-6-ethyl-4-[(3-methoxypropyl)amino]-1-methyl-1,6-dihydroimidazo[4,5-d]pyrrolo[2,3-b]pyridine-7-carboxamide

(1)

584 : (7R)-2-[(3,5-difluoro-4-hydroxyphenyl)amino]-5,7-dimethyl-8-(3-methylbutyl)-7,8-dihydropteridin-6(5H)-one

(1)

5B1 : 5-bromo-1H-indazol-3-amine

(1)

5B2 : 5-phenyl-1H-indazol-3-amine

(1)

5B3 : 4-(3-amino-1H-indazol-5-yl)-N-tert-butylbenzenesulfonamide

(1)

5BS : 4-[(5,10-dimethyl-6-oxo-6,10-dihydro-5H-pyrimido[5,4-b]thieno[3,2-e][1,4]diazepin-2-yl)amino]benzenesulfonamide

(1)

5W2 : 4-[[4-[[3-(~{tert}-butylsulfonylamino)-4-chloranyl-phenyl]amino]-5-methyl-pyrimidin-2-yl]amino]-2-fluoranyl-~{N}-(1-methylpiperidin-4-yl)benzamide

(1)

6DP : ~{N}-(1~{H}-indazol-4-yl)methanesulfonamide

(1)

6T3 : 11-(2-pyrrolidin-1-yl-ethoxy)-14,19-dioxa-5,7,26-triaza-tetracyclo[19.3.1.1(2,6).1(8,12)]heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene

(1)

6TP : 4-amino-2-[4-(tert-butylsulfamoyl)phenyl]-N-methylthieno[3,2-c]pyridine-7-carboxamide

(1)

7DZ : (7S)-2-[(3,5-difluoro-4-hydroxyphenyl)amino]-5,7-dimethyl-8-(3-methylbutyl)-7,8-dihydropteridin-6(5H)-one

(1)

7GS : {2-[6-(2-ethyl-5-fluoro-4-hydroxyphenyl)-2H-indazol-3-yl]-3,4,6,7-tetrahydro-5H-imidazo[4,5-c]pyridin-5-yl}[5-(piperidin-1-yl)pyrazin-2-yl]methanone

(1)

7GT : {(3R,4R)-4-methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl}[(3R)-3-(phenylsulfonyl)pyrrolidin-1-yl]methanone

(1)

7GV : {(3R,4R)-4-methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl}(pyrrolidin-1-yl)methanone

(1)

7GX : 6-(2-ethyl-4-hydroxyphenyl)-N-(6-methylpyridin-3-yl)-1H-indazole-3-carboxamide

(1)

7GY : 6-(2-ethyl-4-hydroxyphenyl)-1H-indazole-3-carboxamide

(1)

7GZ : 4-[3-(1H-benzimidazol-2-yl)-1H-indazol-6-yl]-3-ethylphenol

(1)

88A : 8-(4-methylsulfonylphenyl)-N-(4-morpholin-4-ylphenyl)-[1,2,4]triazolo[1,5-a]pyridin-2-amine

(1)

8MY : 4-({4-amino-6-[3-(hydroxymethyl)-1H-pyrazol-1-yl]pyrimidin-2-yl}amino)benzonitrile

(1)

953 : 5-(2-aminopyrimidin-4-yl)-2-[2-chloro-5-(trifluoromethyl)phenyl]-1H-pyrrole-3-carboxamide

(1)

9HR : 4-[2-[5-(dimethylamino)pentylamino]-8-[[(2~{S})-1-oxidanylpropan-2-yl]amino]quinazolin-6-yl]-5-ethyl-2-fluoranyl-phenol

(1)

9I2 : 4-[2-azanyl-8-[[(2~{S})-1-oxidanylpropan-2-yl]amino]quinazolin-6-yl]-5-ethyl-2-fluoranyl-phenol

(1)

9I5 : 4-(2-azanyl-8-methoxy-quinazolin-6-yl)phenol

(1)

9I8 : 4-[8-methoxy-2-[(1-methylpyrazol-4-yl)amino]quinazolin-6-yl]phenol

(1)

9T6 : 4-[[(1S,3R)-5-oxidanyl-2-adamantyl]amino]-1H-pyrrolo[2,3-b]pyridine-5-carboxamide

(1)

9ZS : N-[2-(2,6-dichlorophenyl)-1H-imidazo[4,5-c]pyridin-4-yl]cyclopropanecarboxamide

(1)

ACE : ACETYL GROUP

(1)

AZ5 : 5-CHLORO-N2-[(1S)-1-(5-FLUOROPYRIMIDIN-2-YL)ETHYL]-N4-(5-METHYL-1H-PYRAZOL-3-YL)PYRIMIDINE-2,4-DIAMINE

(1)

BJG : 2-(5-chloro-2-methylphenyl)-1-methyl-5-(2-{[4-(4-methylpiperazin-1-yl)phenyl]amino}pyrimidin-4-yl)-1H-pyrrole-3-carboxamide

(1)

C87 : Momelotinib

(1)

CL : CHLORIDE ION

(1)

D7D : N-{cis-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]cyclobutyl}propane-1-sulfonamide

(1)

DVY : 4-(4-{[5-amino-3-(4-sulfamoylanilino)-1H-1,2,4-triazole-1-carbonyl]amino}phenyl)pyridine-2-carboxylic acid

(1)

E3W : 4'-{[5-amino-3-(4-sulfamoylanilino)-1H-1,2,4-triazole-1-carbonyl]amino}-4-(benzyloxy)[1,1'-biphenyl]-3-carboxylic acid

(1)

E4V : 4-(5-aminopyrazin-2-yl)-1H-pyrrolo[2,3-b]pyridin-6-amine

(1)

E8I : (2S)-2-[({4-[(2-amino-7H-pyrrolo[2,3-d]pyrimidin-4-yl)oxy]phenyl}carbamoyl)amino]-4-phenylbutanoic acid

(1)

EKT : 2-[[3,5-bis(fluoranyl)-4-oxidanyl-phenyl]amino]-5,7,7-trimethyl-8-(3-methylbutyl)pteridin-6-one

(1)

F9J : 5-FLUORO-4-[(1S)-1-(5-FLUOROPYRIMIDIN-2-YL)ETHOXY]-N-(5-METHYL-1H-PYRAZOL-3-YL)-6-MORPHOLINO-PYRIMIDIN-2-AMINE

(1)

I6C : 3-{(4S)-2-[(cyclopropanecarbonyl)amino]imidazo[1,2-b]pyridazin-6-yl}-N-{3-[(4-ethylpiperazin-1-yl)methyl]-5-(trifluoromethyl)phenyl}-4-methylbenzamide

(1)

IK1 : 5-PHENYL-2-UREIDOTHIOPHENE-3-CARBOXAMIDE

(1)

J2I : 2-(2,6-difluoro-4-methoxyphenyl)-1-(4-{4-[(3-methyl-1H-pyrazol-5-yl)amino]pyrrolo[2,1-f][1,2,4]triazin-2-yl}piperazin-1-yl)ethanone

(1)

J9D : 4-({4-amino-6-[4-(2-hydroxyethyl)-1H-imidazol-1-yl]pyrimidin-2-yl}amino)benzonitrile

(1)

JAK : 2-methyl-1-(piperidin-4-yl)-1,6-dihydroimidazo[4,5-d]pyrrolo[2,3-b]pyridine

(1)

JZH : (3S)-3-(4-hydroxyphenyl)-1,5-dihydro-1,5,12-triazabenzo[4,5]cycloocta[1,2,3-cd]inden-4(3H)-one

(1)

L0I : 4-[(2-{4-[(CYCLOPROPYLCARBAMOYL)AMINO]-1H-PYRAZOL-3-YL}-1H-BENZIMIDAZOL-6-YL)METHYL]MORPHOLIN-4-IUM

(1)

LMM : N2-[(1S)-1-(5-fluoropyrimidin-2-yl)ethyl]-7-methyl-N4-(1-methylimidazol-4-yl)thieno[3,2-d]pyrimidine-2,4-diamine

(1)

M3A : 5-amino-3-[(4-cyanophenyl)amino]-N-phenyl-1H-1,2,4-triazole-1-carboxamide

(1)

M3Y : 5-amino-N-phenyl-3-[(4-sulfamoylphenyl)amino]-1H-1,2,4-triazole-1-carboxamide

(1)

 

More...

EC number / name  (1)

2.7.10.2 : Non-specific protein-tyrosine kinase

(164)

Biological function  (5)

ATP binding

(158)

protein kinase activity

(155)

protein tyrosine kinase activity

(102)

histone binding

(3)

non-membrane spanning protein tyrosine kinase activity

(3)

Biological process  (2)

protein phosphorylation

(158)

intracellular signal transduction

(3)

Biological cell component  (2)

cytoskeleton

(3)

membrane

(3)

CATH class  (2)

Alpha Beta

(86)

Mainly Alpha

(86)

CATH topology  (2)

Phosphorylase Kinase; domain 1

(86)

Transferase(Phosphotransferase); domain 1

(86)

Pfam accession / name  (5)

PF07714 : PK_Tyr_Ser-Thr

(155)

PF17887 : Jak1_Phl

(3)

PF18377 : FERM_F2

(3)

PF18379 : FERM_F1

(3)

PF21990 : SH2_1

(3)

Diffraction protocol  (1)

Single wavelength

(164)

Diffraction radiation source type  (2)

Synchrotron

(135)

Rotating anode

(29)

Diffraction source  (39)

DIAMOND BEAMLINE I03

(23)

RIGAKU MICROMAX-007 HF

(17)

ALS BEAMLINE 5.0.2

(13)

APS BEAMLINE 23-ID-B

(12)

APS BEAMLINE 24-ID-E

(10)

APS BEAMLINE 22-ID

(7)

ESRF BEAMLINE ID23-1

(7)

AUSTRALIAN SYNCHROTRON BEAMLINE MX2

(6)

RIGAKU MICROMAX-007

(6)

ALS BEAMLINE 5.0.1

(5)

APS BEAMLINE 17-ID

(4)

APS BEAMLINE 19-BM

(4)

NSLS BEAMLINE X25

(4)

SLS BEAMLINE X10SA

(4)

APS BEAMLINE 17-BM

(3)

APS BEAMLINE 22-BM

(3)

APS BEAMLINE 24-ID-C

(3)

APS BEAMLINE 31-ID

(3)

SSRL BEAMLINE BL7-1

(3)

APS BEAMLINE 21-ID-D

(2)

APS BEAMLINE 21-ID-G

(2)

CLSI BEAMLINE 08ID-1

(2)

DIAMOND BEAMLINE I02

(2)

ESRF BEAMLINE ID29

(2)

RIGAKU FR-E SUPERBRIGHT

(2)

APS BEAMLINE 19-ID

(1)

APS BEAMLINE 23-ID-D

(1)

DIAMOND BEAMLINE I04

(1)

DIAMOND BEAMLINE I04-1

(1)

ESRF BEAMLINE ID23-2

(1)

NSLS BEAMLINE X4A

(1)

RIGAKU RU200

(1)

RIGAKU RU300

(1)

RIGAKU RUH2R

(1)

SLS BEAMLINE X06SA

(1)

SSRF BEAMLINE BL19U1

(1)

SSRL BEAMLINE BL11-1

(1)

SSRL BEAMLINE BL11-3

(1)

SSRL BEAMLINE BL12-2

(1)

Synchrotron site  (10)

APS

(55)

Diamond

(27)

ALS

(18)

ESRF

(10)

Australian Synchrotron

(6)

SSRL

(6)

NSLS

(5)

SLS

(5)

CLSI

(2)

SSRF

(1)

Diffraction detector type  (3)

Pixel

(90)

CCD

(62)

Image plate

(11)

Refinement software  (6)

PHENIX

(93)

REFMAC

(45)

BUSTER

(23)

CNS

(3)

BUSTER-TNT

(2)

autoBUSTER

(1)

Representative Structures

100%

95%

90%

70%

50%

40%

30%